Abstract
We investigated whether a causal relationship exists between human herpesvirus 6 (HHV-6) and skin rash resembling acute graft-versus-host disease (GVHD) following bone marrow transplantation (BMT). Isolation of HHV-6 was used to monitor active HHV-6 infection in this study. We analyzed 25 episodes of skin rash in 22 recipients. All recipients were seropositive for HHV-6 before BMT. The onset of skin rash started prior to 30 days post transplantation (group A) in 15 of 25 cases, but after that (group B) in the remaining 10 cases. Twenty-five skin tissue samples were obtained from 22 recipients. The HHV-6 genome was detected in four of 15 skin samples from group A, but not detected in those from group B. HHV-6 was isolated from 11 of 22 recipients around 2 to 3 weeks after BMT (range 14 to 28 days after BMT). HHV-6 was isolated at a time between 10 days before and after the onset of skin rash (skin rash-related viremia) in nine cases in group A. Meanwhile, no skin rash-related viremia was observed in group B. Of the four recipients with positive detection of HHV-6 genome in their skin tissue (group A), two had HHV-6 viremia at the same time. The association between the timing of HHV-6 infection and the onset of skin rash was analyzed statistically. HHV-6 viremia (skin rash-related viremia) was found in nine of 15 (60%) cases in group A, compared with none of 10 (0%) cases in group B. This difference was statistically significant (P = 0.008). Moreover, HHV-6 infection (skin rash-related viremia and/or positive detection of HHV-6 DNA in skin tissue) was demonstrated in 11 of 15 (73.3%) cases in group A, compared with none of 10 (0%) cases in group B (P = 0.001). Thus, this study suggests that HHV-6 may be involved in the development of skin rash in the first month after allogeneic BMT. Bone Marrow Transplantation (2001) 28, 77–81.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Salahuddin SZ, Ablashi DV, Markham PD et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders Science 1986 234: 596–601
Yamanishi K, Okuno T, Shiraki K et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum Lancet 1988 1: 1065–1067
Asano Y, Yoshikawa T, Suga S et al. Viremia and neutralizing antibody response in infants with exanthem subitum J Pediatr 1989 114: 535–539
Asano Y, Yoshikawa T, Suga S et al. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia New Engl J Med 1991 324: 634–635
Yoshikawa T, Suga S, Asano Y et al. Human herpesvirus-6 infection in bone marrow transplantation Blood 1991 78: 1381–1384
Wilborn F, Brinkmann V, Schmidt CA et al. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction Blood 1994 83: 3052–3058
Appleton AL, Sviland L, Peiris JSM et al. Human herpesvirus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease Bone Marrow Transplant 1995 16: 777–782
Le Cleach L, Joberty C, Fillet AM et al. Human herpesvirus 6 infection in patients with exanthema after allogeneic bone marrow transplantation Arch Dermatol 1998 134: 759–760
Cone RW, Huang MLW, Corey L et al. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations J Infect Dis 1999 179: 311–318
Takemoto Y, Takatsuka H, Wada H et al. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship Bone Marrow Transplant 2000 26: 77–81
Carrigan DR, Drobyski WR, Russler SK et al. Inter-stitial pneumonitis associated with human herpesvirus 6 infection after marrow transplantation Lancet 1991 338: 147–149
Cone RW, Hackman RC, Huang MW et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation New Engl J Med 1993 329: 156–161
Drobyski WR, Knox KK, Majewski D, Carrigan DR . Brief report: fatal encephalitis due to variant B human herpesvirus 6 infection in a bone marrow-transplant recipient New Engl J Med 1994 330: 1356–1360
Drobyski, WR, Dunne WM, Burd EM et al. Human herpesvirus 6 (HHV-6) infection allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo J Infect Dis 1993 167: 735–739
Wang FZ, Dahl H, Linde A et al. Lymphotropic herpesviruses in allogeneic bone marrow transplantation Blood 1996 88: 3615–3620
Kadakia MP, Rybka WB, Stewart JA et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation Blood 1996 12: 5341–5354
Kondo K, Kondo T, Okuno T et al. Latent herpesvirus 6 infection of human monocytes/macrophages J Gen Virol 1991 72: 1401–1408
Azuma E, Kojima S, Kato K et al. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia Bone Marrow Transplant 1997 19: 1085–1087
Matsuyama T, Horibe K, Kato K, Kojima S . Bone marrow transplantation for children with acute myelogenous leukemia in the first complete remission Eur J Cancer 2000 36: 368–375
Yoshikawa T, Suga S, Asano Y et al. Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus-6) in healthy individuals Pediatrics 1989 84: 675–677
Suga S, Yoshikawa T, Kajita Y et al. Prospective study of persistence and excretion of human herpesvirus 6 in patients with exanthem subitum and their parents Pediatrics 1998 102: 900–904
Acknowledgements
We thank Mrs Akiko Yoshikawa and Ms Maki Sawamura for technical support. Takeda Chemical Industries, Ltd, Osaka, Japan, kindly supplied recombinant human interleukin-2. This work was supported in part by grants from Fujita Health University and the Japan Society for the Promotion of Science (JSPS-RFTF97L00703), and also by a Grant-in-Aid for Scientific Research, the Ministry of Education, Science and Culture, Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshikawa, T., Ihira, M., Ohashi, M. et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 28, 77–81 (2001). https://doi.org/10.1038/sj.bmt.1703099
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703099
Keywords
This article is cited by
-
Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt
Virology Journal (2023)
-
Differentiating Skin Rash After Stem Cell Transplantation: Graft Versus Host Disease, Cutaneous Reactions to Drugs and Viral Exanthema
Current Dermatology Reports (2016)
-
Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT
Bone Marrow Transplantation (2011)
-
Molecular monitoring of viral infections after hematopoietic stem cell transplantation
International Journal of Hematology (2010)
-
Primary infection of human herpesvirus-6 in an infant who received cord blood SCT
Bone Marrow Transplantation (2009)